Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Coeptis Therapeutics Holdings (COEPW) Preferred Shares Issued (2024 - 2025)

Coeptis Therapeutics Holdings has reported Preferred Shares Issued over the past 2 years, most recently at $125000.0 for Q2 2025.

  • Quarterly results put Preferred Shares Issued at $125000.0 for Q2 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $5.5 million (changed N/A YoY), and the annual figure for FY2025 was $5.5 million, up 39.37%.
  • Preferred Shares Issued for Q2 2025 was $125000.0 at Coeptis Therapeutics Holdings, down from $5.3 million in the prior quarter.
  • Over the last five years, Preferred Shares Issued for COEPW hit a ceiling of $5.3 million in Q1 2025 and a floor of $125000.0 in Q2 2025.